Viewing Study NCT06585605



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06585605
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-03

Brief Title: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Sponsor: None
Organization: None

Study Overview

Official Title: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Epilepsy-Dyskinesia Study aims to advance the understanding of the clinical and molecular spectrum of epilepsy-dyskinesia syndromes monogenic diseases that cause both movement disorders and epilepsy Addressing challenges in rare disease research -such as small geographically dispersed patient populations and a lack of standardized protocols- the study employs a multinational retrospective survey endorsed by the International Parkinson and Movement Disorder Society This survey seeks to collect comprehensive data on clinical features disease progression age of onset genetic variants and concurrent neurological conditions standardizing data collection across countries to provide a unified understanding of these conditions Through retrospective review and molecular data analysis the study aims to identify patterns and correlations between movement and seizure disorders uncovering genotype-phenotype relationships The initiative39s goals are to enhance understanding of epilepsy-dyskinesia syndromes inform precision medicine approaches and foster international collaboration
Detailed Description: Overview The Epilepsy-Dyskinesia Study aims to advance the understanding of the clinical and molecular spectrum of epilepsy-dyskinesia syndromes which are monogenic diseases causing both movement disorders and epilepsy

Design Multinational Retrospective Survey

Survey Details Endorsed by the International Parkinson and Movement Disorder Society this multinational retrospective survey seeks to gather comprehensive data on

Clinical Features and Progression Examining developmental history and treatment responses
Disease Aspects Including the age of onset for movement disorders and seizures genetic variants and concurrent neurological conditions

Data Harmonization By standardizing data collection across countries the survey aims to overcome barriers in rare disease research and provide a unified understanding of these conditions

Study Aims This study seeks to broaden our understanding of the spectrum and association of movement and seizure disorders through a retrospective review By analyzing clinical data the study aims to identify patterns and correlations between these conditions while investigating molecular data to uncover underlying genetic and biochemical mechanisms The ultimate goal is to enhance knowledge of how these disorders interact and progress over time offering new insights at both clinical and molecular levels

Overarching Goals

1 Enhance understanding of movement disorders and epilepsy
2 Inform precision medicine approaches
3 Foster international collaboration for rare disease research

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None